DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
4.290
+0.200 (4.89%)
Jun 6, 2025, 1:14 PM - Market open
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $183.97 million as of June 6, 2025. Its market cap has increased by 52.93% in one year.
Market Cap
183.97M
Enterprise Value
138.39M
1-Year Change
52.93%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $183.97M, an increase of 401.28%. That is a compound annual growth rate of 28.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 180.10M | -22.44% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.90B |
| Johnson & Johnson | 370.80B |
| AbbVie | 334.31B |
| Novo Nordisk | 315.80B |
| UnitedHealth Group | 273.96B |
| Abbott Laboratories | 234.15B |
| Novartis AG | 226.74B |
| AstraZeneca | 223.00B |